In the current study, we elucidated a previously unrevealed pathological mechanism of NEC development, in which CCL3 aggravates NEC-related intestinal damage through the CCL3-CCR4-ERK1/2-NK-κB-BAX/BCL2 signalling axis. The gene discussed is CCR4; the disease is necrotizing enterocolitis.